Literature DB >> 15194450

Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice.

J Adriaan Bouwknecht1, Jan van der Gugten, Lucianne Groenink, Berend Olivier, Richard E Paylor.   

Abstract

Serotonin(1A) (5-HT(1A)) receptors are involved in anxiety. This study focuses on the role of genetic factors on the anxiety-related effects of 5-HT(1A) receptor stimulation using both a within subject design. The effects of 5-HT(1A) receptor activation were studied in high- and low-anxiety mice (129S6/SvEvTac (S6) and C57BL/6J (B6), respectively) in behavioral and physiological anxiety-related assays. These two strains were also selected because they are frequently used in gene-targeting studies. Mice were treated with the selective 5-HT(1A) receptor agonist flesinoxan (0-0.3-1.0-3.0 mg/kg s.c.) and tested in either the open-field activity test, the light-dark exploration test, or the stress-induced hyperthermia paradigm. Flesinoxan unexpectedly increased anxiety, but also decreased activity on several behavioral measures in B6 mice. Flesinoxan produced only minimal effects in the behavioral tests in the high-anxiety S6 strain. In contrast, the physiological hyperthermia response showed anxiolytic-like effects of flesinoxan in both strains. Our data indicate that the role of 5-HT(1A) receptor activation on anxiety-related responses is dependent on genetic background and selected paradigm used to assess anxiety. These findings indicate that it is critical to use a multi-level approach to develop mouse models for human diseases. In addition, the implication of such findings for studies on genetically modified mice is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194450     DOI: 10.1016/j.ejphar.2004.04.037

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence creates murine model of major depressive disorder.

Authors:  George S Zubenko; Hugh B Hughes
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-05-19       Impact factor: 3.568

2.  Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes.

Authors:  R J Rodgers; R Augar; N Berryman; C J Hansom; M L O'Mahony; R M Palmer; A Stevens; A J Tallett
Journal:  Psychopharmacology (Berl)       Date:  2006-06-27       Impact factor: 4.530

3.  Behavioral phenotyping of neuropeptide S receptor knockout mice.

Authors:  Dee M Duangdao; Stewart D Clark; Naoe Okamura; Rainer K Reinscheid
Journal:  Behav Brain Res       Date:  2009-07-29       Impact factor: 3.332

4.  Corticosterone level and central dopaminergic activity involved in agile and exploratory behaviours in formosan wood mice (Apodemus semotus).

Authors:  Kun-Ruey Shieh; Shu-Chuan Yang
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2018-03-27       Impact factor: 1.836

Review 5.  Structure-Dependent Activity of Natural GABA(A) Receptor Modulators.

Authors:  Serhat Sezai Çiçek
Journal:  Molecules       Date:  2018-06-22       Impact factor: 4.411

6.  mGluR5 ablation in cortical glutamatergic neurons increases novelty-induced locomotion.

Authors:  Chris P Jew; Chia-Shan Wu; Hao Sun; Jie Zhu; Jui-Yen Huang; Dinghui Yu; Nicholas J Justice; Hui-Chen Lu
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 7.  Preclinical animal anxiety research - flaws and prejudices.

Authors:  Abdelkader Ennaceur; Paul L Chazot
Journal:  Pharmacol Res Perspect       Date:  2016-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.